Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06748729 · ClinicalTrials.gov registry record · NA
Clinical Investigation (Beta) of a New Developed Prosthetic Knee
A NA study of Amputation, sponsored by Össur Iceland ehf.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT06748729: Completed NA study of Amputation, sponsored by Össur Iceland ehf.
NCT06748729 is a NA study of Amputation that has completed, run by Össur Iceland ehf. The registered enrollment target is 11 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06748729, a NA study of Amputation, has completed, sponsored by Össur Iceland ehf.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this investigation is to evaluate the efficacy of the investigational device regarding performance improvements and satisfaction in descending activities for moderate to high active prosthesis users within the intended population for the investigational device. Additionally, the overall satisfaction for activities of daily living will be evaluated after a certain time of use (4 weeks home use).
Primary Outcome
Satisfaction on ramp descent with the new MPK compared to prescribed device In-house questionnaire and Scale used: worse, same, better.
Conditions Studied
Interventions
- DEVICE Navii Knee
Study Locations (1)
Florida
- Össur Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2024-03-28 |
| Phase | NA |
What the finished NCT06748729 record still lists
NCT06748729 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which Navii Knee is the first listed.
NCT06748729 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06748729 about?
NCT06748729 is a clinical study titled "Clinical Investigation (Beta) of a New Developed Prosthetic Knee". The aim of this investigation is to evaluate the efficacy of the investigational device regarding performance improvements and satisfaction in descending activities for moderate to high active prosthesis users within the intended population for the investigational device. Additionally, the overall s...
What is the current status of trial NCT06748729?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2024-02-26. Estimated completion is 2024-03-28.
What conditions does trial NCT06748729 study?
This clinical trial studies the following conditions: Amputation.
What interventions are being tested in trial NCT06748729?
The interventions under investigation include: Navii Knee (DEVICE).
Who is sponsoring clinical trial NCT06748729?
This trial is sponsored by Össur Iceland ehf, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06748729 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06748729's enrollment target sits among peer trials
11 49th of 65 higher than 17 of 65 other Amputation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
-
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI